Patients Living With Arterial Hypertension in Mexico: First Insights of The Mexican Registry of Arterial Hypertension (RIHTA Study)
Authors:
- Silvia Palomo-PiñónSPSilvia Palomo-Piñón
- Neftali Eduardo Antonio-VillaNANeftali Eduardo Antonio-Villa
- Luis Rey García-CortésLGLuis Rey García-Cortés
- Luis AlcocerLALuis Alcocer
- Ernesto G Cardona-MuñozECErnesto G Cardona-Muñoz
- Adolfo Chávez-MendozaACAdolfo Chávez-Mendoza
- Héctor Galván-OsegueraHGHéctor Galván-Oseguera
- Mexican Group of Experts on Arterial HypertensionMHMexican Group of Experts on Arterial Hypertension
- Humberto Álvarez LópezHLHumberto Álvarez López
Open Access
- 11 March 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 37 (7) , 503-513
Abstract
Arterial hypertension is a significant cause of morbidity and mortality in Mexico. However, there is limited evidence to understand blood pressure management and cardiometabolic profiles. Here, we aim to assess the prevalence of controlled and uncontrolled blood pressure, as well as the prevalence of cardiometabolic risk factors among patients from the Mexican Registry of Arterial Hypertension (RIHTA). We conducted a cross-sectional analysis of participants living with arterial hypertension registered on RIHTA between December 2021 and April 2023. We used both the 2017 ACC/AHA and 2018 ESC/ESH thresholds to define controlled and uncontrolled arterial hypertension. We considered eleven cardiometabolic risk factors, which include overweight, obesity, central obesity, insulin resistance, diabetes, hypercholesterolemia, hypertriglyceridemia, low HDL-C, high LDL-C, low-eGFR, and high cardiovascular disease (CVD) risk. In a sample of 5,590 participants (female: 61%, n = 3,393; median age: 64 [IQR: 56–72] years), the prevalence of uncontrolled hypertension varied significantly, depending on the definition (2017 ACC/AHA: 59.9%, 95% CI: 58.6–61.2 and 2018 ESC/ESH: 20.1%, 95% CI: 19.0–21.2). In the sample, 40.43% exhibited at least 5–6 risk factors, and 32.4% had 3–4 risk factors, chiefly abdominal obesity (83.4%, 95% CI: 82.4–84.4), high LDL-C (59.6%, 95% CI: 58.3–60.9), high CVD risk (57.9%, 95% CI: 56.6–59.2), high triglycerides (56.2%, 95% CI: 54.9–57.5), and low HDL-C (42.2%, 95% CI: 40.9–43.5). There is a high prevalence of uncontrolled hypertension interlinked with a high burden of cardiometabolic comorbidities in Mexican adults living with arterial hypertension, underscoring the urgent need for targeted interventions and better healthcare policies to reduce the burden of the disease in our country.Keywords
This publication has 44 references indexed in Scilit:
- New Creatinine- and Cystatin C–Based Equations to Estimate GFR without RaceNew England Journal of Medicine, 2021
- Trends and age-period-cohort effects on hypertension mortality rates from 1998 to 2018 in MexicoScientific Reports, 2021
- Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participantsThe Lancet, 2021
- Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertensionNature Reviews Cardiology, 2021
- Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018JAMA, 2020
- Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic healthClinical Nutrition, 2020
- Quality governance in a pluralistic health system: Mexican experience and challengesThe Lancet Global Health, 2018
- Hypertension in Latin America: Current perspectives on trends and characteristicsHipertensión y Riesgo Vascular, 2017
- A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveysThe Lancet Diabetes & Endocrinology, 2015
- Cardiovascular risk factors in a Mexican middle-class urban population. The Lindavista Study. Baseline dataArchivos de Cardiología de México, 2013